Thomas Anthony Coton

Title: Thomas Anthony Coton: Innovator in Influenza Virus Adaptation

Introduction

Thomas Anthony Coton is a notable inventor based in Singapore, recognized for his contributions to the field of virology. He has been instrumental in developing methods that enhance the adaptation of influenza viruses to Vero cells, which is crucial for vaccine production and research.

Latest Patents

Coton holds two patents, both focusing on a method for adapting influenza viruses to Vero cells. The first patent describes a method that involves infecting Vero cells with the influenza virus, cultivating the infected cells, and harvesting the influenza viruses from each passage. The method ensures that the infectious dose of the influenza viruses from one passage is equal to or greater than that of the previous passage. Additionally, the patent includes a composition that comprises polyriboinosinic acid-polyribocytidylic acid, antibiotics or polyamide compounds, positive ions, and influenza viruses or antigens derived from Vero cell-adapted influenza viruses.

Career Highlights

Coton is currently employed at Yisheng Biopharma (Singapore) Pte Ltd, where he continues to advance his research in virology. His work is pivotal in the development of effective vaccines and therapeutic strategies against influenza.

Collaborations

Coton collaborates with esteemed colleagues such as Yi Zhang and Yuhe Yan, contributing to a dynamic research environment that fosters innovation in the field of biopharmaceuticals.

Conclusion

Thomas Anthony Coton's work in adapting influenza viruses to Vero cells represents a significant advancement in virology and vaccine development. His patents and ongoing research continue to impact the field positively.